CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-27 | Trenschel Robert J. Director | Grant or award · Stock Option (Right to Buy) | +1,298 | 1,298 | ||
| 2021-04-27 | Trenschel Robert J. Director | Grant or award · Stock Option (Right to Buy) | +4,406 | 4,406 | ||
| 2021-04-27 | Trenschel Robert J. Director | Grant or award · Warrant (right to buy) | +40,785 | 40,785 | ||
| 2021-04-27 | Trenschel Robert J. Director | Grant or award · Warrant (right to buy) | +13,595 | 13,595 | ||
| 2021-04-27 | Trenschel Robert J. Director | Grant or award · Warrant (right to buy) | +1,223 | 1,223 | ||
| 2021-04-27 | Neal James R Director | Grant or award · Stock Option (Right to Buy) | +849 | 849 | ||
| 2021-04-27 | Neal James R Director | Grant or award · Stock Option (Right to Buy) | +3,398 | 3,398 | ||
| 2021-04-27 | Neal James R Director | Grant or award · Stock Option (Right to Buy) | +1,359 | 1,359 | ||
| 2021-04-27 | Neal James R Director | Grant or award · Stock Option (Right to Buy) | +5,091 | 5,091 | ||
| 2021-04-27 | Neal James R Director | Grant or award · Stock Option (Right to Buy) | +1,298 | 1,298 | ||
| 2021-04-27 | Neal James R Director | Grant or award · Stock Option (Right to Buy) | +4,406 | 4,406 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award | +1,592 | 1,592 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +4,078 | 4,078 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +27,189 | 27,189 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +6,797 | 6,797 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +477 | 477 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +2,719 | 2,719 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +95,572 | 95,572 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +22,730 | 22,730 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +8,754 | 8,754 |
Page 14 of 21 · 409 trades